Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Vistin Pharma Director's Dealing 2018

Nov 23, 2018

3782_dirs_2018-11-23_615e444d-abf3-47e0-809e-7f807bc7b306.html

Director's Dealing

Open in viewer

Opens in your device viewer

Mandatory notification of trade

Mandatory notification of trade

Valborg Godal Vold, COO of Vistin Pharma ASA, and a primary insider, has on 18

September 2018 sold 50,000 shares in Vistin Pharma ASA at an average price of

NOK 10.58 per share. Following this sale Valborg Godal Vold holds 50,000 shares

in Vistin Pharma ASA.